Natco Pharma
BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01026 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
12.39Net Income/employee - trailing 12 month
32,11,360.00Revenue/employee - most recent fiscal year
61,95,446.00Return on investment - most recent fiscal year
15.26Return on average assets - most recent fiscal year
13.29Receivables turnover - most recent fiscal year
3.26Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
0.80Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
96,21,513.00Return on average assets - 5 year average
10.34Net Income/employee - most recent fiscal year
16,37,029.00Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.50Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
15.66Return on investment - 5 year average
12.04